44
Participants
Start Date
November 14, 2018
Primary Completion Date
April 7, 2020
Study Completion Date
April 7, 2020
Levosimendan
A sterile 2.5 mg/mL concentrate solution that is diluted in 5% Dextrose or 0.9 Normal Saline to achieve a 50 microgram/min solution for infusion
Matching Placebo
A sterile 2.5mg/mL concentrate solution that is diluted in 5% Dextrose or 0.9 Normal Saline to achieve a 50 microgram/min solution for infusion
New York Presbyterian Hospital-Weill Cornell Medicine, New York
Ichan School of Medicine at Mount Sinai, New York
North Shore University Hospital, Manhasset
University of Pittsburgh Presbyterian Hospital, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Medical University of South Carolina, Charleston
Christ Hospital, Cincinnati
UW Health University Hospital, Madison
University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester
Northwestern Memorial Hospital, Chicago
University of Nebraska Medical Center, Omaha
Stanford Healthcare, Stanford
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Tenax Therapeutics, Inc.
INDUSTRY